Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

MedImpact SVP Arpit Patel wins PBMI Innovators award. By re-engineering the drug supply chain and formularies, Patel and the MedImpact team are increasing transparency, predictability and affordability SAN DIEGO, CA - August 6, 2026 - MedImpact MedImpact, the nation's largest independent pharmacy benefits and health solutions company, today announced that Arpit Patel, Senior Vice President of Trade Relations and Supply Chain, has received the 2026 Pharmacy Benefit Management Institute(R)(PBMI) Innovators award. "This award really belongs to our entire team of clinicians, technologists, and industry experts who come to work every day with a passion to make healthcare work better for the millions of people we serve," said Arpit Patel, MedImpact Senior Vice President of Trade Relations and Supply Chain. "It is an honor to receive this award, but it is even more rewarding to know we're making a difference for our clients and members." A leading nonprofit organization focused on advancing the pharmacy benefits industry, PBMI helps health plans, employers, and other stakeholders navigate the complex world of pharmacy benefits in pursuit of improved patient outcomes, lower costs, and a better overall healthcare experience. The PBMI Innovators award recognizes leaders who are implementing cutting-edge pharmacy benefit strategies, contributing fresh insights to the market, and achieving measurable results. Arpit is one of six individuals receiving the award this year. As a senior leader at MedImpact, Arpit is leveraging more than 20 years in healthcare to improve prescription affordability and access by: * Offering interchangeable biosimilars that cost 95% less than the reference; * Delivering a flexible and predictable suite of GLP-1 solutions with built-in lifestyle support; * Spearheading the development of MedPerform(R) Flex, MedImpact's new formulary that lowers costs while preserving access; and * Reimagining how a pharmacy benefit and health solutions company can partner with and serve clients. "Healthcare needs to change and Arpit and his team are at the tip of the spear," said Krista Kelley, MedImpact Chief Commercial Officer, Enterprise. "We are proud to have him as a leader at MedImpact, innovating to improve healthcare for payers and consumers." Keep up to date on the latest in the industry. Client News Biosimilars represent one of the most powerful opportunities to reduce specialty drug costs for payers and members and expand access to effective t Press Releases Strategic expansion strengthens proximity to major East Coast employers and payers while enhancing service for clients east of the Mississippi Press Releases Advancing whole-person care with a personalized, clinically integrated solution that supports women across every stage of life Client News Medication non-adherence is a significant challenge for all healthcare payers but, given its role in CMS Star Ratings, it bears particular weight f